NANO MRNA Co.,Ltd.
Biotechnology firm creating and out-licensing IP for mRNA-based therapeutics.
4571 | T
Overview
Corporate Details
- ISIN(s):
- JP3651120002
- LEI:
- Country:
- Japan
- Address:
- 港区愛宕二丁目５番１号
- Website:
- https://www.nanomrna.co.jp/
Description
NANO MRNA Co., Ltd. is a biotechnology firm that operates as a platform company and an IP Generator specializing in mRNA-based medicine. The company focuses on creating and out-licensing intellectual property for novel therapeutics by connecting drug discovery seeds with medical and development needs. It leverages a proprietary drug delivery system (DDS) based on micellar nanoparticle technology to advance its pipeline. Key clinical programs include an mRNA therapy for osteoarthritis (RUNX1 mRNA) and an antisense oligonucleotide (ASO) for glioblastoma (TUG1 ASO). Evolving from its predecessor, NanoCarrier, the company combines a legacy of R&D in nanoparticle technology with a strategic focus on RNA drug discovery. It also co-developed and markets Comlex®, an antibacterial agent for ear, nose, and throat conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-12 08:04 |
四半期報告書－第25期第1四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | 145.7 KB | ||
| 2020-06-29 08:00 |
有価証券報告書－第24期(平成31年4月1日－令和2年3月31日)
|
Japanese | 808.8 KB | ||
| 2020-02-14 07:01 |
四半期報告書－第24期第3四半期(令和1年10月1日－令和1年12月31日)
|
Japanese | 140.6 KB | ||
| 2019-11-14 08:36 |
四半期報告書－第24期第2四半期(2019/07/01－2019/09/30)
|
Japanese | 204.8 KB | ||
| 2019-08-09 08:01 |
四半期報告書－第24期第1四半期(2019/04/01－2019/06/30)
|
Japanese | 221.3 KB | ||
| 2019-06-27 08:10 |
有価証券報告書－第23期(平成30年4月1日－平成31年3月31日)
|
Japanese | 1005.5 KB | ||
| 2019-02-13 07:03 |
四半期報告書－第23期第3四半期(2018/10/01－2018/12/31)
|
Japanese | 155.4 KB | ||
| 2018-11-09 07:03 |
四半期報告書－第23期第2四半期(2018/07/01－2018/09/30)
|
Japanese | 196.8 KB | ||
| 2018-08-10 08:02 |
四半期報告書－第23期第1四半期(2018/04/01－2018/06/30)
|
Japanese | 190.3 KB | ||
| 2018-06-25 08:02 |
有価証券報告書－第22期(平成29年4月1日－平成30年3月31日)
|
Japanese | 903.7 KB | ||
| 2018-02-14 07:03 |
四半期報告書－第22期第3四半期(2017/10/01－2017/12/31)
|
Japanese | 150.4 KB | ||
| 2017-11-10 07:06 |
四半期報告書－第22期第2四半期(2017/07/01－2017/09/30)
|
Japanese | 184.7 KB | ||
| 2017-08-10 08:02 |
四半期報告書－第22期第1四半期(2017/04/01－2017/06/30)
|
Japanese | 141.0 KB | ||
| 2017-06-26 08:01 |
有価証券報告書－第21期(2016/04/01－2017/03/31)
|
Japanese | 884.7 KB | ||
| 2017-02-14 07:04 |
四半期報告書－第21期第3四半期(2016/10/01－2016/12/31)
|
Japanese | 140.5 KB |
Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NANO MRNA Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
